Galaxa Pharma a/s — Credit Rating and Financial Key Figures

Galaxa Pharma a/s (CVR number: 41183144) is a company from KØBENHAVN. The company recorded a gross profit of -398.9 kDKK in 2025. The operating profit was -403.1 kDKK, while net earnings were -461.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was -25.1 %, which can be considered poor and Return on Equity (ROE) was -55.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -13 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Galaxa Pharma a/s's liquidity measured by quick ratio was 0.9 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.